Skip to main content
. 2016 May;13(4):282–289. doi: 10.11909/j.issn.1671-5411.2016.04.012

Figure 1. Distribution of ticagrelor anti-platelet reactivity measured by TEG in ACS patients.

Figure 1.

Figure 1A and figure 1B represent the distribution of PIADP and MAADP measured by TEG, respectively. ACS: acute coronary syndrome; MAADP: ADP-induced platelet-fibrin clot strength; PIADP: ADP induced platelet inhibition; TEG: thrombelastography.